Approval · Notice of Compliance 3313 · 1997
BLENOXANE: Notice of Compliance 3313
Issued August 7, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3313
- Date
- August 7, 1997
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: treatment of malignant pleural effusion
- Therapeutic class
- Antineoplastic, antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BLENOXANE | Not yet assigned | — |
Medicinal ingredients
- BLEOMYCIN SULFATE 15 UNIT per VIAL